Donor Testing Laboratory
This department operates 18 hours a day, six days a week, including holidays, and is responsible for ensuring that all required screening and supplemental testing is completed for approximately 95,000 allogeneic, autologous and apheresis donations collected at Hoxworth Blood Center in FY10.
This department also ensures that any potentially infectious or sub-standard product is quarantined and discarded to prevent release to general inventory.
Hoxworth Blood Center no longer performs required donor testing on site. Indiana Blood Center serves as the testing facility for Hoxworth Blood Center and has done so since 1998.
Current Food and Drug Administration (FDA) and AABB required testing, in addition to other supplemental testing, is performed to detect/determine:
ABO/Rh;
Antibody to:
Human Immunodeficiency Virus (HIV) Types 1/2, HIV-1 subtypes O and M
Hepatitis B Core (HBC) Antigen
Human T-Lymphotrophic Virus (HTLV) Types I & II
Hepatitis C Virus (HCV)
Syphilis (T. pallidum)
Chagas Disease (T. cruzi)
Red Cell Antigens
Antigen:
Hepatitis B Virus (HBV) Surface Antigen
Nucleic Acid Testing (NAT) for viral RNA for:
HCV
HIV-1
HBV
West Nile Virus (WNV)
Additiontal Testing:
Cholesterol (for donors wishing to track their non-fasting cholesterol levels).
Infectious Disease Testing Information
The Donor Testing Laboratory receives many questions concerning the dates of infectious disease testing. The following table is a brief synopsis on the history and current status of infectious disease testing performed at Hoxworth Blood Center.

